| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Alendronate | FAERS: 8 | US FAERS | |
| 2 | Imatinib Mesylate | FAERS: 4 | US FAERS | |
| 3 | Finasteride | FAERS: 2 | US FAERS | |
| 4 | NuvaRing | FAERS: 2 | US FAERS | |
| 5 | Asenapine | FAERS: 1 | US FAERS | |
| 6 | Atazanavir Sulfate | FAERS: 1 | OFFSIDES US FAERS | |
| 7 | Estrogens, Conjugated (USP) | FAERS: 1 | OFFSIDES US FAERS | |
| 8 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 9 | eletriptan | FAERS: 1 | US FAERS | |
| 10 | tofacitinib | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Progesterone | OFFSIDES | ||
| 12 | rizatriptan | OFFSIDES | ||
| 13 | rizatriptan | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.